There are 2789 resources available
1669O_PR - Late effects, long-term problems, and unmet needs of cancer survivors
Presenter: Martina Schmidt
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1558O - COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
Presenter: Stephen Thomas
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1559O - Efficacy and toxicity of BNT162b2 vaccine in cancer patients
Presenter: Ithai Waldhorn
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1561O - The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
Presenter: Kok Haw Jonathan Lim
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1098O - Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)
Presenter: Maria Carmen Riesco-Martinez
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1096O - Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results from the phase III SPINET study
Presenter: Dieter Horsch
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1097O - The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
Presenter: Rocio Garcia-Carbonero
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1441O - Patient-reported outcomes in cancer patients newly diagnosed with brain metastases
Presenter: Guro Astrup
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1560O_PR - Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection
Presenter: Alessio Cortellini
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
No
Presenter: Martin Reck
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast